Interferon alfa-2b (SRC VB Vector/Vector Medica)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b (SRC VB Vector/Vector Medica)
Drug Alias Name干扰素α-2b(SRC VB Vector/Vector Medica)Reaferon-EU-LipintReaferon-EC-LipintReaferon-ES-Lipint
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2007/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVector MedicaState Research Center Of Virology And Biotechnology Vector
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksWikipedia